Cell-free tumor DNA, CA125 and HE4 for the objective assessment of tumor burden in patients with advanced high-grade serous ovarian cancer.
Heitz F, Lakis S, Harter P, Heikaus S, Sehouli J, Talwar J, Menon R, Ataseven B, Bertrand M, Schneider S, Mariotti E, Bommert M, Müller JN, Prader S, Leenders F, Hengsbach A, Gloeckner C, Braicu EI, Heukamp LC, du Bois A, Heuckmann JM.
Heitz F, et al. Among authors: leenders f.
PLoS One. 2022 Feb 7;17(2):e0262770. doi: 10.1371/journal.pone.0262770. eCollection 2022.
PLoS One. 2022.
PMID: 35130283
Free PMC article.